Your browser doesn't support javascript.
loading
Overcoming the blood-brain barrier by Annexin A1-binding peptide to target brain tumours.
Nonaka, Motohiro; Suzuki-Anekoji, Misa; Nakayama, Jun; Mabashi-Asazuma, Hideaki; Jarvis, Donald L; Yeh, Jiunn-Chern; Yamasaki, Kazuhiko; Akama, Tomoya O; Huang, Chun-Teng; Campos, Alexandre Rosa; Nagaoka, Masato; Sasai, Toshio; Kimura-Takagi, Itsuko; Suwa, Yoichi; Yaegashi, Takashi; Shibata, Toshiaki K; Sugihara, Kazuhiro; Nishizawa-Harada, Chizuko; Fukuda, Minoru; Fukuda, Michiko N.
Affiliation
  • Nonaka M; Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Suzuki-Anekoji M; Laboratory for Drug Discovery, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, 305-8568, Japan.
  • Nakayama J; Department of Biological Chemistry, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
  • Mabashi-Asazuma H; Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Jarvis DL; Department of Molecular Pathology, Shinshu University School of Medicine, Matsumoto, 390-8621, Japan.
  • Yeh JC; Department of Molecular Biology, University of Wyoming, Laramie, WY, 82071, USA.
  • Yamasaki K; Department of Molecular Biology, University of Wyoming, Laramie, WY, 82071, USA.
  • Akama TO; Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Huang CT; Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Ibaraki, 305-8566, Japan.
  • Campos AR; Department of Pharmacology, Kansai Medical University, Hirakata, Osaka, 573-1010, Japan.
  • Nagaoka M; Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Sasai T; Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Kimura-Takagi I; Yakult Central Institute, Kunitachi, Tokyo, 186-8650, Japan.
  • Suwa Y; Yakult Central Institute, Kunitachi, Tokyo, 186-8650, Japan.
  • Yaegashi T; Yakult Central Institute, Kunitachi, Tokyo, 186-8650, Japan.
  • Shibata TK; Yakult Central Institute, Kunitachi, Tokyo, 186-8650, Japan.
  • Sugihara K; Yakult Central Institute, Kunitachi, Tokyo, 186-8650, Japan.
  • Nishizawa-Harada C; Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Fukuda M; Department of Gynecology and Obstetrics, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
  • Fukuda MN; Department of Gynecology and Obstetrics, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Br J Cancer ; 123(11): 1633-1643, 2020 11.
Article in En | MEDLINE | ID: mdl-32921792
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Drug Carriers / Blood-Brain Barrier / Annexin A1 / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Drug Carriers / Blood-Brain Barrier / Annexin A1 / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2020 Type: Article Affiliation country: United States